glp 1 drugs and blood clots GLP-1 medicines may cut clot-related risks in chronically inflamed patients Doctor says GPL-1 causes blood
Description
This finding demonstrates the robust activity of tirzepatide at the alpha cell GIPR that outweighs inhibitory actions produced by GLP-1R agonism and provides additional evidence that tirzepatide has important activity at the GIPR in human islets
in press
Real-world data confirms these results persist when patients maintain medication use and lifestyle modifications
Med Sci Monit (2014) 20:16627
